@article{MTMT:34780026,
	title = {Use of Cemiplimab, an Immune Checkpoint Inhibitor for Conjunctival Intraepithelial Neoplasia},
	url = {https://m2.mtmt.hu/api/publication/34780026},
	author = {Ceylanoglu, K.S. and Eisenberg, A. and Worden, F.P. and Elner, V.M. and Demirci, H.},
	doi = {10.1097/ICO.0000000000003452},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34780026},
	issn = {0277-3740},
	year = {2024},
	eissn = {1536-4798},
	pages = {528-530}
}

@article{MTMT:34735463,
	title = {Reliability and Agreement of Keratometry Measurements Obtained With Eye Surface Profilometry and Partial Coherence Interferometry},
	url = {https://m2.mtmt.hu/api/publication/34735463},
	author = {Martínez-Plaza, E. and Molina-Martín, A. and Piñero, D.P.},
	doi = {10.1097/ICO.0000000000003348},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34735463},
	issn = {0277-3740},
	year = {2024},
	eissn = {1536-4798},
	pages = {343-348}
}

@article{MTMT:34645509,
	title = {Effect of Keratoconus Stage and Classification Parameters on Deep Anterior Lamellar Keratoplasty Outcomes},
	url = {https://m2.mtmt.hu/api/publication/34645509},
	author = {Atik, Burcu Kemer and Emul, Merve and Kirgiz, Ahmet and Cubuk, Mehmet Ozgur and Ahmet, Sibel and Besek, Nilay Kandemir},
	doi = {10.1097/ICO.0000000000003362},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34645509},
	issn = {0277-3740},
	keywords = {keratoconus; Deep anterior lamellar keratoplasty; Amsler-Krumeich classification system; keratoconus stage},
	year = {2024},
	eissn = {1536-4798},
	pages = {327-332},
	orcid-numbers = {Kirgiz, Ahmet/0000-0001-7498-3693; Ahmet, Sibel/0000-0002-1842-4077}
}

@article{MTMT:34645497,
	title = {Long-Term Risk of Steroid-Induced Ocular Hypertension/Glaucoma With Topical Prednisolone Acetate 1% After Descemet Stripping Endothelial Keratoplasty},
	url = {https://m2.mtmt.hu/api/publication/34645497},
	author = {Price, Marianne O. and Price, David A. and Price Jr, Francis W.},
	doi = {10.1097/ICO.0000000000003312},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34645497},
	issn = {0277-3740},
	keywords = {Intraocular pressure; Keratoplasty; OCULAR HYPERTENSION; immunologic rejection; prednisolone acetate 1%; steroid-responsive glaucoma},
	year = {2024},
	eissn = {1536-4798},
	pages = {323-326}
}

@article{MTMT:34644861,
	title = {Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis},
	url = {https://m2.mtmt.hu/api/publication/34644861},
	author = {Caputo, Roberto and Di Grande, Laura and de Libero, Cinzia and Marziali, Elisa and Mori, Francesca and Masini, Marzio},
	doi = {10.1097/ICO.0000000000003368},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34644861},
	issn = {0277-3740},
	keywords = {vernal keratoconjunctivitis; cyclosporine A eye drops; cyclosporine A 0.1% cationic emulsion; moderate vernal keratoconjunctivitis},
	year = {2024},
	eissn = {1536-4798},
	pages = {228-232},
	orcid-numbers = {Marziali, Elisa/0000-0002-6676-9379}
}

@article{MTMT:34626226,
	title = {Validation of the C-DU(KE) Calculator as a Predictor of Outcomes in Patients Enrolled in Steroids for Corneal Ulcer and Mycotic Ulcer Treatment Trials},
	url = {https://m2.mtmt.hu/api/publication/34626226},
	author = {Arboleda, Alejandro and Prajna, N. Venkatesh and Lalitha, Prajna and Srinivasan, Muthiah and Rajaraman, Revathi and Krishnan, Tiruvengada and Mousa, Hazem M. and Feghali, James and Acharya, Nisha R. and Lietman, Thomas M. and Perez, Victor L. and Rose-Nussbaumer, Jennifer},
	doi = {10.1097/ICO.0000000000003313},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34626226},
	issn = {0277-3740},
	keywords = {predictive model; INFECTIOUS KERATITIS; bacterial ulcer; fungal ulcer; C-DU(KE) calculator},
	year = {2024},
	eissn = {1536-4798},
	pages = {166-171},
	orcid-numbers = {Arboleda, Alejandro/0000-0002-5060-1782; Rose-Nussbaumer, Jennifer/0000-0002-4905-2528}
}

@article{MTMT:34514765,
	title = {Ocular Surface Disease in Patients with Atopic Dermatitis Treated with Dupilumab: A Prospective Case-Control Study},
	url = {https://m2.mtmt.hu/api/publication/34514765},
	author = {Marolo, P. and Ribero, S. and Caselgrandi, P. and Ghilardi, A. and De, Sanctis U. and Parisi, G. and Fallico, M. and Borrelli, E. and Ortoncelli, M. and Gelato, F. and Mastorino, L. and Tibaldi, T. and Roccuzzo, G. and Quaglino, P. and Reibaldi, M.},
	doi = {10.1097/ICO.0000000000003341},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34514765},
	issn = {0277-3740},
	abstract = {Purpose:The aim of this study was to evaluate the variation of dry eye disease (DED) prevalence in patients with atopic dermatitis (AD) treated with dupilumab.Methods:This prospective case-control study included consecutive patients with moderate-to-severe AD scheduled for dupilumab between May and December 2021 and healthy subjects. DED prevalence, the Ocular Surface Disease Index, tear film breakup time test, osmolarity, Oxford staining score, and Schirmer test results were collected at baseline, 1 month, and 6 months after dupilumab therapy. The Eczema Area and Severity Index was assessed at baseline. Ocular side effects and discontinuation of dupilumab were also recorded.Results:Seventy-two eyes from 36 patients with AD treated with dupilumab and 36 healthy controls were included. Prevalence of DED increased from 16.7% at baseline to 33.3% at 6 months in the dupilumab group (P = 0.001), whereas it remained unchanged in the control group (P = 0.110). At 6 months, the Ocular Surface Disease Index and Oxford score increased (from 8.5 ± 9.8 to 11.0 ± 13.0, P = 0.068, and from 0.1 ± 0.5 to 0.3 ± 0.6, P = 0.050, respectively), the tear film breakup time test and Schirmer test results decreased (from 7.8 ± 2.6 s to 7.1 ± 2.7 s, P < 0.001, and from 15.4 ± 9.6 mm to 13.2 ± 7.9 mm, P = 0.036, respectively) in the dupilumab group, whereas they remained stable in the control group (P > 0.05). Osmolarity was unchanged (dupilumab P = 0.987 and controls P = 0.073). At 6 months after dupilumab therapy, 42% of patients had conjunctivitis, 36% blepharitis, and 2.8% keratitis. No severe side effects were reported, and none of the patients discontinued dupilumab. No association between Eczema Area and Severity Index and DED prevalence was shown.Conclusions:DED prevalence increased in patients with AD treated with dupilumab at 6 months. However, no severe ocular side effects were found and no patient discontinued therapy. © 2024 Lippincott Williams and Wilkins. All rights reserved.},
	keywords = {Humans; human; Case-Control Studies; Treatment Outcome; Treatment Outcome; Severity of Illness Index; Severity of Illness Index; monoclonal antibody; case control study; Atopic dermatitis; Atopic dermatitis; Dermatitis, Atopic; eczema; eczema; Antibodies, Monoclonal, Humanized; Dry eye disease; Ocular surface; Dupilumab; Dupilumab},
	year = {2024},
	eissn = {1536-4798},
	pages = {221-227}
}

@article{MTMT:34665452,
	title = {Excimer Laser Phototherapeutic Keratectomy for Anterior Corneal Opacification After Descemet Membrane Endothelial Keratoplasty},
	url = {https://m2.mtmt.hu/api/publication/34665452},
	author = {Vernin, Alice and Schrittenlocher, Silvia and Matthaei, Mario and Roters, Sigrid and Siebelmann, Sebastian and Bachmann, Bjoern and Schiller, Petra and Cursiefen, Claus and Schlereth, Simona L.},
	doi = {10.1097/ICO.0000000000003396},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34665452},
	issn = {0277-3740},
	keywords = {PHOTOTHERAPEUTIC KERATECTOMY; Descemet membrane endothelial keratoplasty; BCVA; corneal backscatter},
	year = {2024},
	eissn = {1536-4798},
	pages = {95-104},
	orcid-numbers = {Schiller, Petra/0000-0002-9957-1465}
}

@article{MTMT:34645502,
	title = {Outcomes of Phacoemulsification With Toric Intraocular Lenses in Addressing Postkeratoplasty Astigmatism},
	url = {https://m2.mtmt.hu/api/publication/34645502},
	author = {Moreno-Martinez, Almudena and Martin-Melero, Oscar and Andres-Pretel, Fernando and Gomez-Cortes, Alfonso and Granados-Centeno, Jose M.},
	doi = {10.1097/ICO.0000000000003288},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34645502},
	issn = {0277-3740},
	keywords = {Phacoemulsification; astigmatism; Keratoplasty; Toric intraocular lens},
	year = {2024},
	eissn = {1536-4798},
	pages = {76-82},
	orcid-numbers = {Moreno-Martinez, Almudena/0000-0002-4788-9850}
}

@article{MTMT:34448921,
	title = {Role of Direct Supervision in the Learning Curve of Descemet Membrane Endothelial Keratoplasty Surgery},
	url = {https://m2.mtmt.hu/api/publication/34448921},
	author = {Borgia, A. and Coco, G. and Airaldi, M. and Romano, D. and Pagano, L. and Semeraro, F. and Menassa, N. and Gadhvi, K.A. and Kaye, S.B. and Romano, V.},
	doi = {10.1097/ICO.0000000000003278},
	journal-iso = {CORNEA},
	journal = {CORNEA},
	volume = {43},
	unique-id = {34448921},
	issn = {0277-3740},
	abstract = {Purpose:The aim of this study was to compare complication rates of Descemet membrane endothelial keratoplasty (DMEK) performed by directly supervised and nondirectly supervised corneal fellows.Methods:This study was a retrospective, comparative case series of DMEK surgeries performed by novice surgeons (less than 15 DMEK cases) with or without direct direct expert supervision. Patients who underwent surgery for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy with a minimum follow-up of 12 weeks were included. Data on patients' demographics, surgical details, surgeon level, intraoperative and postoperative complications, and rate of rebubbling were collected.Results:In this study, 41 nondirectly supervised and 48 directly supervised DMEK surgeries were included. At 6 months, 67.4% of eyes achieved a best-corrected visual acuity of & le;0.3 logMAR with no significant difference between groups (P = 0.95). Intraoperative complications occurred in 22% of cases in the nondirect supervision group and 4.2% in the direct supervision group (P = 0.02). Postoperative complications occurred in 9.8% of cases in the nondirect supervision group and 6.2% of cases in the direct supervision group (P = 0.7). The rebubbling rate was comparable in the 2 groups (34.1% vs. 33.3%, P = 1.0). Five cases (12.2%), all from the nondirect supervision group, required secondary keratoplasty (P = 0.02). The overall complication rate was significantly higher in the nondirect supervision group (31.7% vs. 10.4%, P = 0.03).Conclusions:Functional success can be achieved in directly supervised or nondirectly supervised DMEK surgery. However, nondirectly supervised DMEK surgery may associate with higher rates of complications. © 2024 Lippincott Williams and Wilkins. All rights reserved.},
	keywords = {Humans; human; Cell Count; Cell Count; Retrospective Studies; Postoperative complications; retrospective study; visual acuity; visual acuity; postoperative complication; training; cornea endothelium; Endothelium, Corneal; learning curve; learning curve; DMEK; supervision; trainee; Fuchs endothelial dystrophy; lamellar keratoplasty; Fuchs' Endothelial Dystrophy; Descemet membrane; Descemet membrane; Descemet stripping endothelial keratoplasty; Descemet stripping endothelial keratoplasty},
	year = {2024},
	eissn = {1536-4798},
	pages = {52-58}
}